Mineralys Therapeutics, Inc. (MLYS) Tops Q4 EPS by 22c
Tweet
Share
E-mailGet Alerts MLYS Hot Sheet
Join SI Premium – FREE
Mineralys Therapeutics, Inc. (NASDAQ: MLYS) reported Q4 EPS of ($0.61), $0.22 better than the analyst estimate of ($0.83).
For earnings history and earnings-related data on Mineralys Therapeutics, Inc. (MLYS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
- Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
